Clinical Trial Update: Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins

View source ↗

Summary

This completed clinical trial assessed glycemic control and quality of care in patients with type 2 diabetes previously treated with Mixtard insulins who switch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Mixtard (insulin isophane (NPH) and regular insulin)
• NovoMix 30 (insulin aspart protamine fixed-dose combination)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED